VCYT Stock Analysis: Buy, Sell, or Hold?
VCYT - Veracyte, Inc.
$46.32
-13.46 (-22.52%)
▼
5d:
-18.18%
30d:
-22.61%
90d:
+40.7%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Get Alerted When VCYT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: VCYT is down 18.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: VCYT is down 18.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$56.14
Based on 4.3% avg growth
INTRINSIC VALUE TODAY
$34.86
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 24.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VCYT is currently trading at $46.32, which is considered oversold relative to its 30-day fair value range of $54.48 to $59.97. From a valuation perspective, the stock is trading at a premium (Forward PE: 31.7) compared to its historical average (24.1). At these levels, the market is pricing in 9.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, VCYT is in a strong uptrend. Immediate support is located at $43.52, while resistance sits at $59.96. Short-term momentum is weak, with the stock down 22.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VCYT is in a strong uptrend. Immediate support is located at $43.52, while resistance sits at $59.96. Short-term momentum is weak, with the stock down 22.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$54.48 -
$59.97
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
67.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-22.5%)
- BEARISH: Trading above Wall St target ($56.55)
- NEUTRAL: PE elevated vs history but 9.5% growth expectation is conservative given 289% recent growth
- WARNING: Recommendation downgraded due to -18.2% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$54.48 -
$59.97
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$43.52
Resistance Level
$59.96
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
31.67
Wall Street Target
$56.55
(-5.4%)
Revenue Growth (YoY)
21.5%
Earnings Growth (YoY)
288.9%
Profit Margin
16.2%
Valuation Premium vs History
+9.5% premium
PE vs Historical
31.7 vs 24.1
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.5%
(market-implied from PE analysis)
1-Year Target
$65.46
(+10%)
2-Year Target
$71.68
(+20%)
3-Year Target
$78.49
(+31%)
3-Yr Target (if PE normalizes)
(PE: 32→24)
PE COMPRESSION
$59.72
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 31.7, Growth: 4.6%)
$68.49
(+15%)
Base:
(SPY PE: 20.8, Growth: 4.6%)
$45.00
(-25%)
Bear:
(PE: 17.7, Growth: 4.6%)
$38.25
(-36%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (32x PE), but valuation improves significantly next year (32x PE) as earnings recover.
Forward PE: 32.36 | Forward EPS (Implied): $1.43
Bull Case
$55.93
(+21%)
Analyst growth 15.0%, PE expands to 34.0
Base Case
$46.32
(0%)
Market implied 0.0%, PE stable at 32.4
Bear Case
$35.43
(-24%)
Severe decline -15.0%, PE contracts to 29.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 02, 2026 10:17 AM ET
Data refreshes hourly during market hours. Next update: 11:17 AM
Data refreshes hourly during market hours. Next update: 11:17 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VCYT showing a specific setup today?
Insider Activity (6 Months)
1
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
John Leite
SELL
5260 shares
2026-03-04
Marc Stapley
SELL
45523 shares
2026-03-04
Rebecca Chambers
SELL
18341 shares
2026-03-04
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$630 | 53 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$188 | 61 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$283 | 59 HOLD |
